AbbVie Inc. (ABBV) Interest Expense USD 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
AbbVie Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2024.
  • AbbVie Inc. Interest Expense for the quarter ending March 31, 2024 was $660 M, a 19.3% increase year-over-year.
  • AbbVie Inc. Interest Expense for the twelve months ending March 31, 2024 was $2.33 B, a 4.3% increase year-over-year.
  • AbbVie Inc. annual Interest Expense for 2023 was $2.22 B, a 0.27% decline from 2022.
  • AbbVie Inc. annual Interest Expense for 2022 was $2.23 B, a 7.97% decline from 2021.
  • AbbVie Inc. annual Interest Expense for 2021 was $2.42 B, a 1.26% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.33 B $660 M +$107 M +19.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $2.22 B $564 M -$2 M -0.35% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $2.23 B $555 M -$5 M -0.89% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $2.23 B $552 M -$4 M -0.72% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $2.24 B $553 M +$5 M +0.91% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $2.23 B $566 M -$14 M -2.41% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $2.24 B $560 M -$36 M -6.04% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $2.28 B $556 M -$59 M -9.59% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $2.34 B $548 M -$84 M -13.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $2.42 B $580 M -$49 M -7.79% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $2.47 B $596 M -$34 M -5.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $2.51 B $615 M -$17 M -2.69% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.52 B $632 M +$69 M +12.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $2.45 B $629 M +$70 M +12.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $2.38 B $630 M +$150 M +31.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $2.23 B $632 M +$274 M +76.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $1.96 B $563 M +$176 M +45.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $1.78 B $559 M +$179 M +47.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $1.61 B $480 M +$141 M +41.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $1.46 B $358 M +$38 M +11.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $1.43 B $387 M +$78 M +25.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $1.35 B $380 M +$80 M +26.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $1.27 B $339 M +$46 M +15.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $1.22 B $320 M +$36 M +12.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $1.19 B $309 M +$36 M +13.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $1.15 B $300 M -$16 M -5.06% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $1.17 B $293 M +$22 M +8.12% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $1.14 B $284 M +$39 M +15.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.11 B $273 M +$58 M +27% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $1.05 B $316 M +$108 M +51.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $939 M $271 M +$64 M +30.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $875 M $245 M +$73 M +42.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $802 M $215 M +$83 M +62.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $719 M $208 M +$70 M +50.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $649 M $207 M +$59 M +39.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $590 M $172 M +$99 M +136% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $491 M $132 M +$62 M +88.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $429 M $138 M +$65 M +89% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $364 M $148 M +$73 M +97.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $291 M $73 M -$6 M -7.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $297 M $70 M -$2 M -2.78% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $299 M $73 M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $75 M +$65 M +650% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $79 M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $72 M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q3 2012 $10 M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.